The extracted data underscore that the somatic mutations in ACTB and ACTG1 do not occur haphazardly across cancers and that the higher frequency observed in two skin cancer and two DLBCL studies merits further investigation. Here, ACTB is linked to diffuse large B-cell lymphoma.